Neuro-Oncology Biotech Industry Progress Report 2025

Neuro-oncology is central to the rapidly expanding field of cancer therapeutics, with surges in clinical trials exploring innovative treatment strategies. The 2025 Brain Tumor Biotech Summit was hosted by Northwell Health Lenox Hill Hospital's Department of Neurosurgery, the Feinstein Institute for Medical Research, and the Zucker School of Medicine in New York City in June 2025. The summit highlighted recent advancements in neuro-oncology, with a focus on emerging treatments, novel drug delivery platforms, and device-based therapeutics. Leaders from academia, biotechnology, and investment communities presented progress on clinical trials, early-phase technologies, and personalized treatment strategies for glioblastoma (GBM) and other CNS tumors. This report summarizes the key discussions at the summit and emphasizes the importance of translational partnerships in accelerating therapy development for glioma patients.